B-cell non-Hodgkins lymphoma is a diverse group of blood cancers originating from abnormal B lymphocytes and includes several clinically distinct subtypes. Advances in oncology research, molecular diagnostics, immunotherapy, and targeted treatment approaches are reshaping how these malignancies are identified and managed. Increasing emphasis on personalized treatment, improved disease...